HIGHLIGHTS
- who: Tadayuki Ishibashi et al. from the Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan have published the research: Identification of Spinal Inhibitory Interneurons Required for Attenuating Effect of Duloxetine on Neuropathic Allodynia-like Signs in Rats, in the Journal: Cells 2022, 11, 4051. of /2022/
- what: The authors investigated the mechanism by which duloxetine modulates neuropathic pain by focusing on an SDH inhibitory interneuron subset (captured by an adeno-associated viral vector including a rat neuropeptide Y promoter; AAV-NpyP+ neurons), which has previously been identified as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.